Matinas BioPharma Holdings logo
Matinas BioPharma Holdings MTNB
$ 3.57 0.0%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Matinas BioPharma Holdings Long Term Debt Current 2011-2024 | MTNB

Annual Long Term Debt Current Matinas BioPharma Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
656 K 562 K 539 K 391 K 424 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
656 K 391 K 514 K